Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kerwin, R. W.
and
Aitchison, K. J.
1997.
Cost-effectiveness of clozapine.
British Journal of Psychiatry,
Vol. 171,
Issue. 6,
p.
584.
Taylor, David M.
1997.
Establishing cost-effectiveness of antipsychotic drugs.
British Journal of Psychiatry,
Vol. 171,
Issue. 5,
p.
486.
Knapp, Martin
1997.
Costs of schizophrenia.
British Journal of Psychiatry,
Vol. 171,
Issue. 6,
p.
509.
Robert, G. B.
and
Kennedy, Peter F.
1997.
Establishing cost-effectiveness of atypical neuroleptics.
British Journal of Psychiatry,
Vol. 171,
Issue. 2,
p.
103.
Percudani, Mauro
and
Knapp, Martin
1998.
The economic perspective in the care and treatment of patients with diagnosis of schizophrenia.
Epidemiologia e Psichiatria Sociale,
Vol. 7,
Issue. 3,
p.
197.
Lauriello, John
Mathalon, Daniel H.
Rosenbloom, Margaret
Sullivan, Edith V.
Faustman, William O.
Ringo, David L.
Lim, Kelvin O.
and
Pfefferbaum, Adolf
1998.
Association between regional brain volumes and clozapine response in schizophrenia.
Biological Psychiatry,
Vol. 43,
Issue. 12,
p.
879.
Tobin, Margaret
and
Hickie, Ian
1998.
Outcomes Focused Service Delivery: Developing an Academic-Management Partnership.
Australian & New Zealand Journal of Psychiatry,
Vol. 32,
Issue. 3,
p.
327.
Höffler, J.
Uber, A.
Trenckmann, U.
and
von der Schulenburg, J.-M. Graf
1998.
Therapie mit klassischen und neuen Neuroleptika.
p.
159.
Fichtner, Christopher G
Hanrahan, Patricia
and
Luchins, Daniel J
1998.
Pharmacoeconomic Studies of Atypical Antipsychotics: Review and Perspective.
Psychiatric Annals,
Vol. 28,
Issue. 7,
p.
381.
Zito, Julie Magno
1998.
PHARMACOECONOMICS OF THE NEW ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA.
Psychiatric Clinics of North America,
Vol. 21,
Issue. 1,
p.
181.
DeQuardo, John R
and
Tandon, Rajiv
1998.
Review Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?.
Journal of Psychiatric Research,
Vol. 32,
Issue. 3-4,
p.
229.
McCrone, Paul
Thornicroft, Graham
Phelan, Michael
Holloway, Frank
Wykes, Til
and
Johnson, Sonia
1998.
Utilisation and costs of community mental health services.
British Journal of Psychiatry,
Vol. 173,
Issue. 5,
p.
391.
Percudani, M.
Fattore, G.
Galletta, J.
Mita, P. L.
Contini, A.
and
Altamura, A. C.
1999.
Health care costs of therapy‐refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy.
Acta Psychiatrica Scandinavica,
Vol. 99,
Issue. 4,
p.
274.
Lecompte, Damien
and
Cookson, Ron F
1999.
The economic value of atypical antipsychotics: A comparison of risperidone and olanzapine revisited.
International Journal of Psychiatry in Clinical Practice,
Vol. 3,
Issue. 1,
p.
3.
Fleischhacker, W. Wolfgang
1999.
The psychopharmacology of schizophrenia.
Current Opinion in Psychiatry,
Vol. 12,
Issue. 1,
p.
53.
Degner, D.
Adler, L.
Müller, P.
and
Rüther, E.
1999.
Leponex.
p.
120.
Bristow, M. F.
1999.
Usage of clozapine and the new neuroleptics.
Psychiatric Bulletin,
Vol. 23,
Issue. 8,
p.
478.
Gilbody, Simon M
and
Petticrew, Mark
1999.
Rational decision-making in mental health: the role of systematic reviews.
The Journal of Mental Health Policy and Economics,
Vol. 2,
Issue. 3,
p.
99.
Wahlbeck, Kristian
Cheine, Maxim V
Essali, Adib
and
Wahlbeck, Kristian
1999.
Cochrane Database of Systematic Reviews.
Taylor, David
and
Aitchison, Katherinej
1999.
The pharmaco-economics of atypical antipsychotics.
International Journal of Psychiatry in Clinical Practice,
Vol. 3,
Issue. 4,
p.
237.
eLetters
No eLetters have been published for this article.